gastroparesis with semaglutide side effect: in 69-year-old female GLP-1 and Gastroparesis: Clinical Safety

In contrast, the DO-HEALTH randomized clinical trial, which enrolled over 2,150 older adults across Europe (mean age of 75 years), tested a combination of vitamin D3 supplementation (2000 IU/day), omega-3 fatty acids (1 g/day), and a strength-training program over a three-year period

NICE guidance (NG23) recommends HRT as first-line pharmacological treatment for women with moderate to severe menopausal symptoms, provided there are no contraindications

Retatrutide is an investigational 39-amino-acid, fatty-acid-acylated triple agonist engineered to engage the GIP, GLP-1, and glucagon receptors from a single peptide backbone

Complete guidance on optimal capsule administration timing, food interactions, storage requirements, and integration with existing supplements or medications for maximum efficacy

Struggling with allergies

Side effect profiles for each drug also vary, though common effects can include gastrointestinal issues